These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 17929388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pyrazinamide-induced sideroblastic anemia.
    Colucci G, Silzle T, Solenthaler M.
    Am J Hematol; 2012 Mar; 87(3):305. PubMed ID: 21818765
    [No Abstract] [Full Text] [Related]

  • 4. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG, Lötter AP.
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
    [No Abstract] [Full Text] [Related]

  • 5. [Centrofacial granulomatous inflammation].
    Maetzke J, Hinrichs R, Sigge A, Scharffetter-Kochanek K.
    Hautarzt; 2007 Nov; 58(11):976-8. PubMed ID: 17476470
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A case of tuberculous peritonitis in a hemodialysis patient revealed by severe diarrhea and stomachache].
    Hara M, Hatta T, Ohtani M, Segawa H, Ueno R, Sawada K.
    Nihon Jinzo Gakkai Shi; 2013 Nov; 55(1):77-82. PubMed ID: 23461214
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Disseminated extrapulmonary tuberculosis with skin, lymph node and bone involvement].
    Gómez Rodríguez N, Ibáñez Ruán J, Ferreiro Seoane JL, Sevillano Castaño J.
    An Med Interna; 1999 Oct; 16(10):525-6. PubMed ID: 10603672
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
    Ul-Ain Q, Sharma S, Khuller GK.
    Antimicrob Agents Chemother; 2003 Sep; 47(9):3005-7. PubMed ID: 12937014
    [Abstract] [Full Text] [Related]

  • 11. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.
    Probl Tuberk Bolezn Legk; 2004 Sep; (3):32-7. PubMed ID: 15338898
    [Abstract] [Full Text] [Related]

  • 12. [Tuberculoma complicating tuberculous meningitis: description of one paediatric case].
    Ruggeri C, Valenzise M, Alosi MM, Scibilia G, Wasniewska M.
    Minerva Pediatr; 2005 Oct; 57(5):329-32. PubMed ID: 16205620
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 16. Treatment of tuberculous peritonitis.
    Marrón B, Ortiz A.
    Perit Dial Int; 2000 Dec; 20(6):828-9. PubMed ID: 11405183
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hepatic tuberculosis: a case with pseudotumours form].
    Sève P, Boibieux A, Biron F, Bouhour D, Rode A, Bancel B, Chidiac C, Peyramond D.
    Ann Med Interne (Paris); 1998 Oct; 149(6):386-8. PubMed ID: 9853049
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.